Advisory Committee To Review GSK/Adolor’s Entereg
This article was originally published in The Pink Sheet Daily
Executive Summary
Firms hope to get the drug on the market before Wyeth/Progenics’ competing methylnaltrexone for treatment of postoperative ileus.